RxDoctor Payments Data

Stacey Heppert, PA

Physician Assistant · Fuquay Varina, NCNPI 1477539781

Payments from drug & device makers

$1,466in general payments, 2019–2025

Across 71 payments — averaging $20.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$342
  • Lilly USA, LLC$247
  • AbbVie$229
  • Boehringer Ingelheim$145
  • Exact Sciences$119
  • AstraZeneca$103
  • plus $281 from 7 others

What the payments were for

  • Food & beverage$1,466100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,466 in reported general payments places this provider in the 75th percentile of 7,441 physician assistant providers in North Carolina.

See all physician assistant providers in North Carolina

Medicare billing

Part B allowed, 2024
$48,818
Medicare patients
183
Services billed
719

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide22$31,751
JardianceEmpagliflozin21$30,841
TrulicityDulaglutide15$21,486
Soliqua 100-33Insulin Glargine/Lixisenatide11$10,268
VascepaIcosapent Ethyl12$9,710
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog15$4,750
Dexlansoprazole DrDexlansoprazole15$3,363
Rosuvastatin Calcium195$1,779
Levothyroxine Sodium160$1,673
Atorvastatin Calcium224$1,661
Nano 2nd Gen Pen NeedlePen Needle, Diabetic13$1,596
SynthroidLevothyroxine Sodium19$1,509
Pantoprazole Sodium116$1,458
Albuterol Sulfate HfaAlbuterol Sulfate58$1,298
Potassium Chloride48$1,202

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$342$31,75122 claims
Boehringer IngelheimJardiance$145$30,84121 claims
Lilly USA, LLCTrulicity$247$21,48615 claims
AbbVieSynthroid$229$1,50919 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 7,441 physician assistant providers in North Carolina.

Other physician assistant in Fuquay Varina

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →